Selection of Specific Nanobodies against Lupine Allergen Lup an 1 for Immunoassay Development
2021
Yaozhong Hu | Chuan Zhang | Feier Yang | Jing Lin | Yi Wang | Sihao Wu | Ying Sun | Bowei Zhang | Huan Lv | Xuemeng Ji | Yang Lu | Serge Muyldermans | Shuo Wang
The declaration of lupine supplements is mandatory to avoid lupine allergy for sensitive individuals. However, reliable detection methods against lupine allergen remain critical to prevent the unintended consumption of allergen contaminated food. In this study, we have immunized an alpaca with lupine protein extracts and retrieved nanobodies (Nbs). Nevertheless, the target antigen has been recognized as Lup an 1, which has been classified as β-conglutin, and confirmed to connect with lupine allergy. After selection of the best Nb-pair, a sandwich enzyme-linked immunosorbent assay (ELISA) has been developed providing a linear range of 0.036–4.4 μg/mL with detection limit of 1.15 ng/mL. This immunoassay was confirmed by detecting the samples with spiked allergen, and a recovery from 86.25% to 108.45% with coefficient of variation (CV) less than 4.0% has been determined. Generally, this study demonstrated the selection of Nbs against allergen with crude protein content to develop the immunoassay for lupine surveillance in foods.
显示更多 [+] 显示较少 [-]